SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
24-May-24 4:12 PM View: | Trevi Therapeutics, Inc. (TRVI) | 22-May-24 | Option Exercise | 16,043 | $0.51 | $8,197.97 | 39% 41.59K to 57.63K | |
24-May-24 4:12 PM View: | Trevi Therapeutics, Inc. (TRVI) | 22-May-24 | Option Sale | 4,350 | $2.64 | $11,484.90 | (8%) 57.63K to 53.28K | |
12-Oct-23 4:00 PM View: | Trevi Therapeutics, Inc. (TRVI) | 11-Oct-23 | Option Exercise | 2,292 | $0.51 | $1,171.21 | 7% 34.39K to 36.69K | |
12-Oct-23 4:00 PM View: | Trevi Therapeutics, Inc. (TRVI) | 11-Oct-23 | Planned Option Sale | 785 | $2.02 | $1,585.70 | (2%) 36.69K to 35.9K | |
13-Sep-23 4:06 PM View: | Trevi Therapeutics, Inc. (TRVI) | 11-Sep-23 | Option Exercise | 2,291 | $0.51 | $1,170.70 | 7% 32.81K to 35.1K | |
13-Sep-23 4:06 PM View: | Trevi Therapeutics, Inc. (TRVI) | 11-Sep-23 | Planned Option Sale | 711 | $2.20 | $1,564.20 | (2%) 35.1K to 34.39K | |
14-Aug-23 4:00 PM View: | Trevi Therapeutics, Inc. (TRVI) | 11-Aug-23 | Option Exercise | 2,292 | $0.51 | $1,171.21 | 7% 31.2K to 33.5K | |
14-Aug-23 4:00 PM View: | Trevi Therapeutics, Inc. (TRVI) | 11-Aug-23 | Planned Option Sale | 682 | $2.36 | $1,609.52 | (2%) 33.5K to 32.81K | |
12-Jul-23 4:29 PM View: | Trevi Therapeutics, Inc. (TRVI) | 11-Jul-23 | Option Exercise | 2,292 | $0.51 | $1,171.21 | 8% 29.6K to 31.89K | |
12-Jul-23 4:29 PM View: | Trevi Therapeutics, Inc. (TRVI) | 11-Jul-23 | Planned Option Sale | 687 | $2.34 | $1,607.58 | (2%) 31.89K to 31.2K | |
14-Jun-23 4:28 PM View: | Trevi Therapeutics, Inc. (TRVI) | 12-Jun-23 | Option Exercise | 2,291 | $0.51 | $1,170.70 | 8% 27.92K to 30.21K | |
14-Jun-23 4:28 PM View: | Trevi Therapeutics, Inc. (TRVI) | 12-Jun-23 | Planned Option Sale | 610 | $2.64 | $1,610.40 | (2%) 30.21K to 29.6K | |
15-May-23 4:00 PM View: | Trevi Therapeutics, Inc. (TRVI) | 11-May-23 | Option Exercise | 2,291 | $0.51 | $1,170.70 | 9% 26.19K to 28.48K | |
15-May-23 4:00 PM View: | Trevi Therapeutics, Inc. (TRVI) | 11-May-23 | Planned Option Sale | 562 | $2.89 | $1,624.18 | (2%) 28.48K to 27.92K | |
12-Apr-23 5:02 PM View: | Trevi Therapeutics, Inc. (TRVI) | 11-Apr-23 | Option Exercise | 2,292 | $0.51 | $1,171.21 | 9% 24.74K to 27.03K | |
12-Apr-23 5:02 PM View: | Trevi Therapeutics, Inc. (TRVI) | 11-Apr-23 | Planned Option Sale | 840 | $1.84 | $1,544.76 | (3%) 27.03K to 26.19K | |
15-Mar-23 4:00 PM View: | Trevi Therapeutics, Inc. (TRVI) | 13-Mar-23 | Option Exercise | 2,291 | $0.51 | $1,170.70 | 10% 23.34K to 25.63K | |
15-Mar-23 4:00 PM View: | Trevi Therapeutics, Inc. (TRVI) | 13-Mar-23 | Planned Option Sale | 892 | $1.75 | $1,563.85 | (3%) 25.63K to 24.74K | |
15-Feb-23 4:01 PM View: | Trevi Therapeutics, Inc. (TRVI) | 13-Feb-23 | Option Exercise | 27,500 | $0.51 | $14,052.50 | 638% 4.31K to 31.81K | |
15-Feb-23 4:01 PM View: | Trevi Therapeutics, Inc. (TRVI) | 13-Feb-23 | Planned Option Sale | 8,474 | $2.45 | $20,761.30 | (27%) 31.81K to 23.34K |